Procter & Gamble gets FDA approval for drug . U . S . Food and Drug Administration has cleared Procter & Gamble Co ' s request to market a prescription duodenal ulcer drug therapy , the company said on Thursday . Procter and Gamble said it planned to begin selling its patented drug therapy in mid - November , promoting it among health care professionals and managed care organizations . The drug , called Helidac Therapy , combines three drugs , namely bismuth subsalicylate , metronidazole and tetracycline hydrochloride , it said . The company said the drug eradicates the bacterium " Helicobacter pylori ( H . pylori ) " from the stomach and small intestine and , in combination with an H2 antagonist , helps heal ulcers . The bacteria cause about 90 percent of duodenal ulcers , which afflict about one in 12 people during their lifetime , it said . - - New York Newsdesk 212 859 - 1610 
